DICE Therapeutics, Inc.

NasdaqGM:DICE Stock Report

Mkt Cap: US$1.5b

DICE Therapeutics Financial Health

How is DICE Therapeutics's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: DICE's short term assets ($267.8M) exceed its short term liabilities ($11.7M).

Long Term Liabilities: DICE's short term assets ($267.8M) exceed its long term liabilities ($12.2M).


Debt to Equity History and Analysis

Debt Level: DICE is debt free.

Reducing Debt: DICE had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: DICE has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: DICE has sufficient cash runway for 2 years if free cash flow continues to reduce at historical rates of 48.3% each year.


Discover healthy companies